447 related articles for article (PubMed ID: 32169218)
21. Differential regulation of CD103 (αE integrin) expression in human dendritic cells by retinoic acid and Toll-like receptor ligands.
Roe MM; Swain S; Sebrell TA; Sewell MA; Collins MM; Perrino BA; Smith PD; Smythies LE; Bimczok D
J Leukoc Biol; 2017 May; 101(5):1169-1180. PubMed ID: 28087652
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells.
León B; Martínez del Hoyo G; Parrillas V; Vargas HH; Sánchez-Mateos P; Longo N; López-Bravo M; Ardavín C
Blood; 2004 Apr; 103(7):2668-76. PubMed ID: 14630812
[TBL] [Abstract][Full Text] [Related]
23. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation.
Kaplanov I; Carmi Y; Kornetsky R; Shemesh A; Shurin GV; Shurin MR; Dinarello CA; Voronov E; Apte RN
Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1361-1369. PubMed ID: 30545915
[TBL] [Abstract][Full Text] [Related]
24. Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy.
Schetters STT; Rodriguez E; Kruijssen LJW; Crommentuijn MHW; Boon L; Van den Bossche J; Den Haan JMM; Van Kooyk Y
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690667
[TBL] [Abstract][Full Text] [Related]
25. The homeobox protein VentX reverts immune suppression in the tumor microenvironment.
Le Y; Gao H; Bleday R; Zhu Z
Nat Commun; 2018 Jun; 9(1):2175. PubMed ID: 29872044
[TBL] [Abstract][Full Text] [Related]
26. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.
Fang DD; Tang Q; Kong Y; Wang Q; Gu J; Fang X; Zou P; Rong T; Wang J; Yang D; Zhai Y
J Immunother Cancer; 2019 Nov; 7(1):327. PubMed ID: 31779710
[TBL] [Abstract][Full Text] [Related]
27. Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease.
Sanders TJ; McCarthy NE; Giles EM; Davidson KL; Haltalli ML; Hazell S; Lindsay JO; Stagg AJ
Gastroenterology; 2014 May; 146(5):1278-88.e1-2. PubMed ID: 24503130
[TBL] [Abstract][Full Text] [Related]
28. TNF skews monocyte differentiation from macrophages to dendritic cells.
Chomarat P; Dantin C; Bennett L; Banchereau J; Palucka AK
J Immunol; 2003 Sep; 171(5):2262-9. PubMed ID: 12928370
[TBL] [Abstract][Full Text] [Related]
29. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
30. Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy.
Tsang YW; Huang CC; Yang KL; Chi MS; Chiang HC; Wang YS; Andocs G; Szasz A; Li WT; Chi KH
BMC Cancer; 2015 Oct; 15():708. PubMed ID: 26472466
[TBL] [Abstract][Full Text] [Related]
31. In vitro induction of mucosa-type dendritic cells by all-trans retinoic acid.
Saurer L; McCullough KC; Summerfield A
J Immunol; 2007 Sep; 179(6):3504-14. PubMed ID: 17785784
[TBL] [Abstract][Full Text] [Related]
32. Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity.
Suryawanshi A; Hussein MS; Prasad PD; Manicassamy S
Front Immunol; 2020; 11():122. PubMed ID: 32132993
[TBL] [Abstract][Full Text] [Related]
33. CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model.
Wang R; Chen J; Wang W; Zhao Z; Wang H; Liu S; Li F; Wan Y; Yin J; Wang R; Li Y; Zhang C; Zhang H; Cao Y
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35086948
[TBL] [Abstract][Full Text] [Related]
34. IL-4 and retinoic acid synergistically induce regulatory dendritic cells expressing Aldh1a2.
Zhu B; Buttrick T; Bassil R; Zhu C; Olah M; Wu C; Xiao S; Orent W; Elyaman W; Khoury SJ
J Immunol; 2013 Sep; 191(6):3139-51. PubMed ID: 23960232
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages.
Lehtonen A; Veckman V; Nikula T; Lahesmaa R; Kinnunen L; Matikainen S; Julkunen I
J Immunol; 2005 Nov; 175(10):6570-9. PubMed ID: 16272311
[TBL] [Abstract][Full Text] [Related]
36. Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside.
Ghorbaninezhad F; Asadzadeh Z; Masoumi J; Mokhtarzadeh A; Kazemi T; Aghebati-Maleki L; Shotorbani SS; Shadbad MA; Baghbanzadeh A; Hemmat N; Bakhshivand M; Baradaran B
Life Sci; 2022 May; 297():120466. PubMed ID: 35271882
[TBL] [Abstract][Full Text] [Related]
37. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
Petty AJ; Li A; Wang X; Dai R; Heyman B; Hsu D; Huang X; Yang Y
J Clin Invest; 2019 Dec; 129(12):5151-5162. PubMed ID: 31638600
[TBL] [Abstract][Full Text] [Related]
38. Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapy.
Li J; Ma A; Zhang R; Chen Y; Bolyard C; Zhao B; Wang C; Pich T; Li W; Sun N; Ma Q; Wen H; Clinton SK; Carson WE; Li Z; Xin G
Cancer Immunol Immunother; 2024 Feb; 73(3):52. PubMed ID: 38349405
[TBL] [Abstract][Full Text] [Related]
39. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
Hubert P; Roncarati P; Demoulin S; Pilard C; Ancion M; Reynders C; Lerho T; Bruyere D; Lebeau A; Radermecker C; Meunier M; Nokin MJ; Hendrick E; Peulen O; Delvenne P; Herfs M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33712445
[TBL] [Abstract][Full Text] [Related]
40. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment.
Fu C; Jiang A
Front Immunol; 2018; 9():3059. PubMed ID: 30619378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
